Neoadjuvant chemotherapy in pancreatic cancer: still many unanswered questions (Letter to the editor)

Jain, AnkitYip, DesmondGananadha, Sivakumar2023-02-152168-6262http://hdl.handle.net/1885/285227We congratulate Perri et al for publishing the comparative analysis of fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic adenocarcinoma (PDAC).1application/pdfen-AU© 2021 The authorsNeoadjuvant chemotherapy in pancreatic cancer: still many unanswered questions (Letter to the editor)202110.1001/jamasurg.2020.62762021-12-02